Cargando…
The Prevalence and Treatment Costs of Non-Melanoma Skin Cancer in Cluj-Napoca Maxillofacial Center
Background and Objectives: An increasing incidence of non-melanoma skin cancer (NMSC) is noted, as well as an increasing cost of the treatment, with NMSC becoming a public health problem. We aimed to investigate the prevalence and treatment costs of surgically treated NMSC from the Oral and Maxillof...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9968035/ https://www.ncbi.nlm.nih.gov/pubmed/36837422 http://dx.doi.org/10.3390/medicina59020220 |
_version_ | 1784897414390349824 |
---|---|
author | Faur, Cosmin Ioan Moldovan, Mădălina Anca Văleanu, Mădălina Rotar, Horațiu Filip, Laura Roman, Rareș Călin |
author_facet | Faur, Cosmin Ioan Moldovan, Mădălina Anca Văleanu, Mădălina Rotar, Horațiu Filip, Laura Roman, Rareș Călin |
author_sort | Faur, Cosmin Ioan |
collection | PubMed |
description | Background and Objectives: An increasing incidence of non-melanoma skin cancer (NMSC) is noted, as well as an increasing cost of the treatment, with NMSC becoming a public health problem. We aimed to investigate the prevalence and treatment costs of surgically treated NMSC from the Oral and Maxillofacial Surgery Department of Cluj-Napoca County Hospital. Materials and Methods: We retrospectively analyzed the clinical data and the charge data of hospitalization from the informatic system of Cluj-Napoca County Hospital. All patients benefited from standard surgical excision with the reconstruction of the post-excisional defect. A statistical analysis of the costs related to the patients’ features, period and conditions of hospitalization, materials, medication, and paraclinical investigations was performed. Results: Between 2015 and 2019, 133 patients with NMSC were addressed to our department, with basal cell carcinoma (BCC) being four-fold higher than squamous cell carcinoma (SCC). Most NMSC cases were diagnosed in stage I or II, and they benefited from local reconstruction. The treatment costs progressively increased in the last five years, reaching a total cost of EUR ~13.000 in 2019. The treatment cost per episode was higher for SCC compared to BCC, while the total cost of treatment in 5 years was higher for BCC. Low income, immunosuppression, comorbidities, flap reconstruction option, long-lasting surgery, and prolonged hospitalization were associated with an increased cost of the treatment. Conclusion: The prevalence and treatment cost of surgically treated NMSC of the head and neck region increased in the last five years, with high-cost drivers being related to patients and treatment options. |
format | Online Article Text |
id | pubmed-9968035 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-99680352023-02-27 The Prevalence and Treatment Costs of Non-Melanoma Skin Cancer in Cluj-Napoca Maxillofacial Center Faur, Cosmin Ioan Moldovan, Mădălina Anca Văleanu, Mădălina Rotar, Horațiu Filip, Laura Roman, Rareș Călin Medicina (Kaunas) Article Background and Objectives: An increasing incidence of non-melanoma skin cancer (NMSC) is noted, as well as an increasing cost of the treatment, with NMSC becoming a public health problem. We aimed to investigate the prevalence and treatment costs of surgically treated NMSC from the Oral and Maxillofacial Surgery Department of Cluj-Napoca County Hospital. Materials and Methods: We retrospectively analyzed the clinical data and the charge data of hospitalization from the informatic system of Cluj-Napoca County Hospital. All patients benefited from standard surgical excision with the reconstruction of the post-excisional defect. A statistical analysis of the costs related to the patients’ features, period and conditions of hospitalization, materials, medication, and paraclinical investigations was performed. Results: Between 2015 and 2019, 133 patients with NMSC were addressed to our department, with basal cell carcinoma (BCC) being four-fold higher than squamous cell carcinoma (SCC). Most NMSC cases were diagnosed in stage I or II, and they benefited from local reconstruction. The treatment costs progressively increased in the last five years, reaching a total cost of EUR ~13.000 in 2019. The treatment cost per episode was higher for SCC compared to BCC, while the total cost of treatment in 5 years was higher for BCC. Low income, immunosuppression, comorbidities, flap reconstruction option, long-lasting surgery, and prolonged hospitalization were associated with an increased cost of the treatment. Conclusion: The prevalence and treatment cost of surgically treated NMSC of the head and neck region increased in the last five years, with high-cost drivers being related to patients and treatment options. MDPI 2023-01-23 /pmc/articles/PMC9968035/ /pubmed/36837422 http://dx.doi.org/10.3390/medicina59020220 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Faur, Cosmin Ioan Moldovan, Mădălina Anca Văleanu, Mădălina Rotar, Horațiu Filip, Laura Roman, Rareș Călin The Prevalence and Treatment Costs of Non-Melanoma Skin Cancer in Cluj-Napoca Maxillofacial Center |
title | The Prevalence and Treatment Costs of Non-Melanoma Skin Cancer in Cluj-Napoca Maxillofacial Center |
title_full | The Prevalence and Treatment Costs of Non-Melanoma Skin Cancer in Cluj-Napoca Maxillofacial Center |
title_fullStr | The Prevalence and Treatment Costs of Non-Melanoma Skin Cancer in Cluj-Napoca Maxillofacial Center |
title_full_unstemmed | The Prevalence and Treatment Costs of Non-Melanoma Skin Cancer in Cluj-Napoca Maxillofacial Center |
title_short | The Prevalence and Treatment Costs of Non-Melanoma Skin Cancer in Cluj-Napoca Maxillofacial Center |
title_sort | prevalence and treatment costs of non-melanoma skin cancer in cluj-napoca maxillofacial center |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9968035/ https://www.ncbi.nlm.nih.gov/pubmed/36837422 http://dx.doi.org/10.3390/medicina59020220 |
work_keys_str_mv | AT faurcosminioan theprevalenceandtreatmentcostsofnonmelanomaskincancerinclujnapocamaxillofacialcenter AT moldovanmadalinaanca theprevalenceandtreatmentcostsofnonmelanomaskincancerinclujnapocamaxillofacialcenter AT valeanumadalina theprevalenceandtreatmentcostsofnonmelanomaskincancerinclujnapocamaxillofacialcenter AT rotarhoratiu theprevalenceandtreatmentcostsofnonmelanomaskincancerinclujnapocamaxillofacialcenter AT filiplaura theprevalenceandtreatmentcostsofnonmelanomaskincancerinclujnapocamaxillofacialcenter AT romanrarescalin theprevalenceandtreatmentcostsofnonmelanomaskincancerinclujnapocamaxillofacialcenter AT faurcosminioan prevalenceandtreatmentcostsofnonmelanomaskincancerinclujnapocamaxillofacialcenter AT moldovanmadalinaanca prevalenceandtreatmentcostsofnonmelanomaskincancerinclujnapocamaxillofacialcenter AT valeanumadalina prevalenceandtreatmentcostsofnonmelanomaskincancerinclujnapocamaxillofacialcenter AT rotarhoratiu prevalenceandtreatmentcostsofnonmelanomaskincancerinclujnapocamaxillofacialcenter AT filiplaura prevalenceandtreatmentcostsofnonmelanomaskincancerinclujnapocamaxillofacialcenter AT romanrarescalin prevalenceandtreatmentcostsofnonmelanomaskincancerinclujnapocamaxillofacialcenter |